Create a Profile
New Migraine Study
Are you or a loved one living with Migraine?
You can help local researchers learn more about an investigational medicine
for Migraine in a new clinical trial at Accel Research Sites.
To qualify, you must:*
- Be aged 18 or older
- Have an established diagnosis of Migraine
- Have experienced an inadequate response to oral calcitonin gene-related peptide (CGRP) inhibitors, such as Ubrelvy (ubrogepant) and Nurtec (rimegepant)
*Additional criteria must also be met. Our study team will help determine if you qualify.